Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

IXEKIZUMAB
(Taltz (TN))

[1] Ixekizumab (Taltz)

[1] Ixekizumab (Taltz (TN)) 💬

[1] IL17A 💬

[6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬

[8] 36, 37, 46, 107, 160, 162, 269, 271 💬

Disease ID	Name
36	Epidermolysis bullosa
37	Generalised pustular psoriasis
46	Malignant rheumatoid arthritis
107	Juvenile idiopathic arthritis
160	Congenital ichthyosis
162	Pemphigoid
269	Pyogenic arthritis
271	Ankylosing spondylitis

2

[1] Ixekizumab (Taltz)

[1] Ixekizumab (Taltz (TN)) 💬

[1] IL17A 💬

[6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬

[3] 36, 107, 271 💬

3

Taltz (80 mg solution for injection in pre-filled syringe)

[1] Ixekizumab (Taltz)

[1] Ixekizumab (Taltz (TN)) 💬

[1] IL17A 💬

[6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬

[2] 107, 271 💬

4

[1] Ixekizumab (Taltz)

[1] Ixekizumab (Taltz (TN)) 💬

[1] IL17A 💬

[6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬

[1] 36 💬